The clinical presentation of 48 patients with amebic liver abscess was no different than that reported in earlier studies. However, most patients were from countries endemic for parasitic disease, Failure to consider this diagnosis resulted in potentially avoidable surgery for six patients. Although metronidazole was successful primary therapy in 850/0 of 41 patients so treated, four of seven ruptured abscesses occurred in cases where metronidazole treatment failed. For assessment of factors that might predict metronidazole treatment failures, multiple parameters were analyzed. Of the factors evaluated, only timing of clinical response correlated with successful therapy. Ninety-four percent of metronidazole responders showed dramatic clinical improvement within 72 hours of initiation of therapy, whereas only 33% nonresponders had improved modestly during this time (P = .0014). Therefore, early diagnosis of amebic liver abscess in patients from endemic areas and treatment with metronidazole will result in successful therapy in 85% of cases. Surgical intervention or alternative medical therapy is indicated for those patients who do not respond after 72 hours of metronidazole therapy.
At Olive View Medical Center, a 120-bed Los Angeles county hospital located in the San Fernando
Valley, E. histolytica is the commonest cause of liver abscess. The present study is a review of the cases of amebic liver abscess seen at Olive View Medical Center from July 1975 through July 1982. The purpose of this study was to assess the clinical effectiveness of metronidazole therapy. A number of patients failed to respond to metronidazole, often with serious consequences. We felt that an evaluation of these failures might disclose predictive factors and, thus, those patients at risk for developing complication of amebic abscess.
Patients
The charts of all patients discharged with the diagnosis of amebic liver abscess were reviewed. The diagnosis was considered correct if the patients met the following criteria: an intrahepatic defect by a scanning procedure of the liver and a positive serologic test for amebiasis. This was defined as an indirect hemagglutination (IHA) titer of >1 :256 or other serologic equivalent.
All 48 cases of amebic liver abscess included in this retrospective review met the above criteria. Thirty-nine (81070) of the patients were males. The age range was from 11 months to 69 years (mean, 28 years), but the majority of patients were in their 41 
Laboratory Profile
The laboratory profile of the patients in this series is shown in table 3. Most patients were mildly to moderately anemic. The white blood cell counts were routinely elevated, although values >20,OOO/mm 3 were uncommon. Eosinophilia was not seen, but the differential analysis revealed a shift to the left. Of the tests of hepatic function, the prothombin time proved to be the most sensitive, since the results were abnormal in 75% of the patients. Results of the remaining hepatic function tests were normal in the majority of cases. Most abnormalities of the liver shown by the tests were mild, generally less than two pleural effusion was present in nine patients and correlated with pleuric chest or shoulder pain.
In table 2 are listed the most common admitting diagnoses for our patients. Cholecystitis was the most frequent diagnosis followed by abdominal pain of unknown etiology, amebic liver abscess, and appendicitis. In 10% of the cases, the initial impression was that of a pulmonary disease. A host of other conditions -including pancreatitis, gastroenteritis, malaria, lymphoma, tuberculosis, pansinusitis, otitis media, and juvenile rheumatoid arthritis -were considered as the initial diagnosis in the remainder of the patients. The correct admitting diagnosis of amebic liver abscess was suspected in only 16% of cases. The commonest clinical findings are listed in table 1. The majority of the patients had been ill for less than one week. Abdominal pain and fever were the most frequent symptoms. Nausea, vomiting, and chills were present in less than one-half of the patients. Pleuritic chest pain and right shoulder pain suggestive of a pulmonary focus occurred in approximately one-fourth of the patients. Anorexia and significant diarrhea were infrequent, and a history of blood per rectum, rare.
On physical examination all patients except one were febrile, and in 44070 the temperature on admission was >39 C. Most of the patients (52.5070) had abdominal tenderness, usually located in the right upper quadrant but occasionally in the right lower quadrant. Patients with hepatic abscesses of the left lobe frequently had epigastric tenderness. Approximately one-fourth of patients exhibited abdominal guarding. Hepatomegaly, identified by a span to percussion >9 em was present in more than one-half of the patients in this series. An abdominal mass was palpated in five patients. Evidence for Clinical Presentation third or fourth decade of life. Forty-five of the patients were from Mexico or other countries where amebiasis is endemic, and 73% of these had either been in the United States for less than one year or had returned to their country of origin within one year. Three of the patients were born in the United States; of these, one was an ll-month-old girl born in Los Angeles County shortly after her parents had arrived from Mexico, and another, a 43-yearold man who had traveled to Mexico 12 months before admission. Table 3 . Laboratory data for patients with amebic liver abscess.
Diagnosis
A variety of scanning procedures were used to substantiate the diagnosis of amebic liver abscess in times the normal value. Roentgenograms of the chest were abnormal in one-half of the cases, and the abnormalities encountered included elevated hemidiaphragm, pleural effusion, atelectasis, and pulmonary infiltrate.
Admitting diagnosis our patients. Scanning techniques to confirm the presence of space-occupying lesions in the liver included [99Tc]sulfur colloid scans (heptic scans), ultrasonic scans, and 6 7 Ga scans. Hepatic scans were performed on 35 patients and were confirmatory in all, whereas ultrasonic scans were performed on 23 patients and were positive for 22. Gallium scans were positive in all seven patients so examined.
Serologic diagnosis was made by an elevated amebic IHA in 46 patients, a positive counterimmunoelectrophoresis in one patient, and a positive indirect fluorescent antibody test in another. In general, the IHA titer was markedly elevated, with 72070 of cases having a reciprocal titer of~1,024 (figure 2). The counterimmunoelectrophoresis was positive four of six times performed, and the indirect fluorescent antibody test was positive, with a titer of >1:200, in all five patients tested.
The number of abscesses and their location in each patient was assessed by use of the scan data. A total of 59 separate abscesses were identified in our 48 pateints, with nine patients having more than one. Twenty-nine percent of the abscesses were located in the superior or superior-posterior aspect of the right lobe of the liver, and 8.5070 were located in the left lobe. The remaining abscesses were distributed in the rest of the right lobe of the liver. Metronidazole, administered either po or iv for 10-14 days, was the therapeutic modality most frequently employed in this series. As shown in figure  3 , this drug was the primary initial therapy in 41 of the patients in this series and was successful 85% of the time. There were six failures with metronidazole. One subsequently required surgical intervention following rupture, and another five were switched to emetine plus chloroquine after metronidazole proved ineffective. Three of these five patients were subsequently cured on this regimen, but the remaining two patents required intervention for persistent symptoms. Six of the seven patients not treated initially with metronidazole underwent surgery (table 4) . Five of these operations were therapeutic, resulting in drainage of the abscess, and one was a diagnostic error. The remaining patient of the 48 in our series was treated initially with emetine plus chloroquine successfully. All 48 patients were treated successfully, and there were no deaths or bacterial superinfection. A total of 11 surgical procedures were performed. Three patients whose treatment with metronidazole failed ultimately underwent surgical drainage of their abscess. In two children and one adult the amebic abscess was discovered in the postoperative period after an exploration for presumed appendicitis proved negative. In addition, two other adults also underwent exploratory surgery for presumed appendicitis. The abscesses in these two patients were both drained, but in only one had pretreat-
Complications
There were four complications after appropriate therapy was begun among these 48 patients with amebic liver abscesses; each complication occurred in a patient who failed to respond to metronidazole. Two patients suffered intraabdominal rupture of their abscess. The first of these underwent surgical exploration and subsequently recovered. The second patient developed acute hypotension, bronchospasm with subsequent adult respiratory distress syndrome, and acute renal failure. This patient was considered too ill for surgery, was treated Table 4 . Initial treatment other than metronidazole for seven patients with amebic liver abscess. ment rupture occurred. The last three surgical cases included one child operated on for pretreatment rupture of an abscess and two adults undergoing exploratory surgery for diagnosis and therapy of hepatic masses of unknown etiology.
There were eight patients who underwent surgical drainage of an amebic liver abscess in the series. Two of these were pretreatment ruptures as discussed above. Two other patients had abdominal explorationrand abscess drainage for hepatic masses of unknown etiology. One adult patient had his nonruptured abscess drained during an exploratory laparotomy for presumed appendicitis. The three remaining patients failed treatment with metronizadole. One was an 18-month-old child with a hepatobronchopleural fistula who had transthoracic drainage of the abscess cavity following transtracheal aspiration of the abscess contents. Another was a 40-year-old man who initially responded to metronidazole only to have one of his abscesses rupture on day 2 of therapy. The last patient failed to respond to four days of metronidazole treatment and six days of emetine and chloroquine and had his abscess drained on day 11. In each instance following abscess drainage, the patient made a complete recovery. Success (2) FJ:
STery (1) Success (3) Metronidazole ( Of the nine patients with more than one identifiable abscess, six were in the group of patients successfully treated with metronizadole and three were in the metronidazole-failure group. A greater percentage of these latter patients (50070 vs. 17070) had multiple abscesses, but since that group was so small and most of the patients with multiple abscess were in the success group (six vs. three), the apparent difference between the two groups is not significant (P> .09).
The locations of the amebic liver abscesses in each group were analyzed and no trends existed. The most common location in both groups was the superior portion of the liver, with 44070 of the abscesses in the failure group and 30070 of the abscesses in the success group so located. Expressed another way and considering both groups together, 13 of the 17 superiorly located abscesses were in the success group as were four of the six inferior abscesses, five of the six deep-seated abscesses, and seven of the nine posterior abscesses. Surprisingly, none of the patients whose treatment failed had left lobe abscesses, but three of the five left lobe abscesses in the entire series were in the metronidazole-success group.
The volume and surface area of each abscess in each patient in both groups were measured by use of the scanning data. For those patients with more than one abscess, each abscess was considered individually, and then a total volume and total surface area were calculated for each patient. It is well known that amebic liver abscesses are not real abscesses but, rather, are bacteriologically sterile necrotic foci in symptomatically and switched to a regimen of emetine plus chloroquine, and eventually made a complete recovery. The abscesses of two other patients ruptured into the pleural cavity with the development of a hepatobronchopleural fistula. One patient spontaneously coughed up his abscess, and the second, the child aged 18 months, also coughed up her abscess while undergoing endotracheal intubation prior to a transthoracic drainage of the intrathoracic material. After suctioning of the tracheobranchial tree, subsequent thoracic and abdominal exploration revealed that the entire contents of the abscess had been removed transbronchially.
Three patients presented at the hospital with pretreatment rupture of their abscess. One child underwent laparotomy because of severe abdominal pain and tenderness. A ruptured abscess was encountered and drained, and this child made a complete recovery. One 20-year-old man with a liver abscess located on the right superior lobe and a concomitant, large, right-sided pleural effusion was treated with thoracentesis and metronidazole. The fluid was thick, odorless, beige, and culturenegative. Last, a 26-year-old man was operated on for acute appendicitis, and a perforated abscess on the right posterior lobe was found and drained. This patient was treated with metronidazole postoperatively, and he, likewise, made a complete recovery.
Analysis of Metronidazole Treatment Failure
Although all of the patients whose abscesses ruptured eventually recovered, the potential for further catastrophe existed; this prompted us to analyze the differences between the patients treated successfully and unsuccessfully with metronidazole. The median age of the 35 patients in the successfully treated group was 28 years, and that of the six patients in the failure group, 35 years. The mean duration of longest symptom was 6.0 and 6.5 days, respectively. A number of other clinical parameters are listed in table 5. In all categories, the difference between the two groups is not statistically significant. Surprisingly, more of the successfully treated patients complained of chills, abdominal pain, and chest pain, whereas those in whom metronidazole failed more often had hepatomegaly, a temperature >39.0 C, and leukocytosis >15,000/mm measurements, the range in the successfully treated patients was 22.5-905 em" with a median of 144em", and in the metronidazole failure patients, the range was 47-382 em" with a median of 245 em". Because the number of patients in the metronidazole-failure group is so small, we utilized the Mann-Whitney U test to test the hypothesis that the abscesses in both groups, if combined, are part of the same population of abscesses. In summary, for both volume and surface-area measurements, we have no reason to believe that the abscesses in the metronidazole-failure group are different from those in the successfully treated group. Therefore, the apparent differences in the medians of the two groups are not statistically significant. Finally, we analyzed timing of clinical response to metronidazole to see if any differences between the two groups existed. The treatment summaries of the patients for whom metronidazole treatment failed are listed in table 6. Only two of these patients Thompson, Forlenza, and Verma (nos. 3 and 6) had any clinical response to metronidazole at all. Patient no. 3 improved immediately, but then his abscess ruptured on the second day of therapy. Patient no. 6 likewiseimproved immediately and underwent a complete therapeutic course of metronidazole' only to have his symptoms recur following cessation of the drug. None of the other patients had responded to therapy by the fourth day, and in three of these rupture subsequently occurred. In contradistinction, analysis of the data from 35 patients who responded to metronidazole revealed that they each had a dramatic clinical response following the institution of metronidazole therapy, with 66070 of them being almost completely free of fever, pain, and abdominal tenderness within 24 hr of therapy. By 72 hr, in 33 of the 35 metronidazole-success patients, symptoms had almost completely resolved ( figure  4 ). This apparent difference in the clinical response of the two groups is statistically significant (P = .0014, Fisher's exact test).
Pediatric Patients
This series includes six children <12 years of age. The youngest is an ll-month-old girl born in the United States to Mexican emigrants. Her abscess ruptured before initiation of therapy, and she underwent an exploratory laparotomy and drainage. Postoperatively she was placed on dehydroemetine therapy, and she made an uneventful recovery. The next oldest was the 18-month-old girl who developed the hepatobronchopleural fistula and had transthoracic drainage of the abscess cavity. Two five-year-old children were treated with metronidazole and emetine plus chloroquine, respectively, Other treatment, comments
Changed to E + C*; abscess continued to expand with development of hepatobronchopleural fistula; patient went to surgery on day 15 Probable abscess rupture on day 6; patient developed acute respiratory distress, renal failure, and hypotension; no surgery; changed to E + C Acute pain on day 2 of therapy; surgical drainage of ruptured abscess; metronidazole and emetine given postoperatively Abscess continued to expand with development of hepatobronchopleural fistula; changed to E +C; on day 6, patient coughed up abscess
Changed to E + C, no response; surgical drainage on day 10 Metronidazole discontinued; symptoms recurred; changed to E + C on day 14 * E + C = emetine plus chloroquine. and made uneventful recoveries. The last two children were aged six and 11 years, and they each underwent an abdominal exploration for appendicitis. The amebic abscesses were discovered in the postoperative period when the symptoms persisted. Subsequent treatment was metronidazole in one and emetine plus chloroquine in the other; both had dramatic responses. In none of the children was the correct diagnosis of amebic liver abscess entertained on admission to the hospital. a significant minority of patients presented with findings atypical for a primary intrahepatic process -such as pleuritic chest pain and right shoulder pain -suggesting a primary pulmonary process. In addition, although there were few children in this series, they tended to present a more nonspecific picture with less well-localized abdominal pain.
Although amebic liver abscess is not an exotic disease at Olive View Medical Center and most physicians on the faculty and house staff are very aware of the entity, the diagnosis was seldom entertained on admission. Routine laboratory tests were not helpful. Most patients presented with a mild, normochromic, normocytic anemia and a moderately elevated white blood cell count with a shift to the left. Surprisingly, with the exception of the prothrombin time, the results of biochemical tests usually associated with intrinsic hepatic disease were normal in the majority of cases and, when abnormal, were so only to a modest degree. The most common abnormality seen in these tests was the prothrombin time, which was prolonged in 750/0 of patients. Therefore, the routine chemistries should not be used to suggest or rule out the diagnosis. The diagnosis of liver abscess at the time of the review by DeBakey and Ochsmer [7] was an inexact art. The chest roentgenogram was a particularly helpful test in that series and was abnormal in more than onehalf of the patients in this series. However, the findings were nonspecific and in several cases erroneously suggested an intrapulmonary process. The development of hepatic imaging by means of nucleotide and ultrasonic scans has vastly facilitated the diagnosis of intrahepatic defects. Such techniques have rendered the intrahepatic injection of air or iodized oil obsolete. In our experience the [99Tc]sulfur colloid and 67Ga hepatic scans and hepatic ultrasound were all reliable tests for the demonstration of an intrahepatic, space-occupying lesion.
While scanning procedures can establish the presence of an intrahepatic defect, they do not establish an etiologic diagnosis. Fortunately, several serologic tests have proved to be sensitive in diagnosing a hepatic amebic abscess. The IHA test is readily available and is one of the oldest of the serologic tests; it was performed for 46 of the 48 patients. The reciprocal titers in 69% of these patients were~1,024. Midway through the series our hospital changed commercial laboratories providing amebic IHA test, and the values for reciprocal titers were distinctly lower in those results obtained from the second lab- Although the incidence of amebiasis has decreased during the last 30 years, the epidemiology appears to be changing from that of disease occurring in native-born North Americans living in the rural southeastern United States to one occurring primarily in urban immigrants from countries where intestinal protozoa are endemic. In addition, intestinal amebiasis has been recently reported to occur hyperendemically within the homosexual community [6] . The data reported in this article confirm the occurrence of amebic liver abscess in individuals from endemic areas of the world. Since DeBakey and Ochsner [7] reported on amebic liver abscesses in 1951, the age, sex predilection, and clinical picture have not changed. The primary clinical abnormalities in the present series included pain in the right upper quadrant, fever, and hepatomegaly. However, oratory. Although titer did not correlate with degree or duration of illness or with number or size of abscess, one should be aware that value for the reciprocal titer depends upon the standardization of the antigen, which may vary from one laboratory to another. Most patients had a single abscess of the right lobe, although 19070 of patients had multiple abscesses, and 8.5% of the abscesses were in the left lobe. The clinical presentation was not influenced by the number or size of the abscesses, but it was influenced by the location of the abscess cavity. Those patients with abscesses in the left lobe tended to present with midline or epigastric pain, whereas those with primarily pulmonary symptoms had superior right lobe abscesses. Katzenstein et al. [8] have recently reviewed a 10-year experience with amebic liver abscess in 67 patients in San Diego. While they found significant differences in various aspects of the clinical and laboratory presentation between those patients symptomatic for <10 days or more than two weeks, we did not find such a classification system helpful in analyzing our cases. We found no differences in clinical or laboratory parameters between acutely ill and more chronically ill patients.
A number of recent reviews of amebic liver abscess have evaluated the clinical presentation, diagnosis, and complications of the disease [8] [9] [10] . None have specifically evaluated the effectiveness of metronidazole. Powell et al. evaluated several regimens of metronidazole and found them to be 100% ef- Thompson, Forlenza, and Verma fective [11] . However, isolated treatment failures of amebic liver abscess have been reported [12, 13] .Metronidazole was the primary therapy in most of our patients, but we have experienced several therapeutic failures with metronidazole. All of the complications occurred in this group of patients.
We therefore analyzed a number of clinical, laboratory, and therapeutic parameters to determine whether any could predict which patients would fail to respond to metronidazole therapy and be at risk to develop complications. Only the timing of response to metronidazole significantly correlated with therapeutic failures. Patients successfully treated with metronidazole had a dramatic clinical response, usually becoming afebrile and free of pain within 24-48 hr. Ninety-four percent of those responding to metronidazole were asymptomatic by 72 hr, many requesting to be discharged to return to work at that time. In contrast, only two of the metronidazolefailure patients had responded by 72 hr, and these experienced only transient improvement.
Our current approach to the management of patients with amebic liver abscess is outlined in the algorithm in figure 5 . All patients are started on metronidazole therapy; however, if dramatic clinical improvement has not occurred by 72 hr, metronidazole is discontinued, and emetine plus chloroquine is started. Further treatment is then individualized on the basis of the response to these medications.
In contrast to our experience is that of Perches et al. from Mexico, based on the treatment of 1,998 patients with amebic liver abscess [14] . They believe 
+ Response
Continue E + C* for 14 days that severely ill patients should receive metronidazole and emetine in combination from the outset rather than metronidazole alone as we have proposed. We feel that this is not necessary, as many severely ill patients will be cured with metronidazole, and, hence, we prefer to withhold alternative medical therapy until metronidazole failure has been established. In summary, although most patients presented clinically with right upper-quadrant pain and fever, others presented a clinical picture less suggestive of the diagnosis of amebic liver abscess. Therefore, a high index of suspicion of this diagnosis must be maintained for immigrants or travelers from countries endemic for E. histolytica. The diagnosis can be readily established by hepatic scanning procedures and amebic serologic tests, whereas routine hematologic tests and chemical analyses are not helpful. While most patients will respond rapidly to metronidazole, those who fail to respond by 72 hr are at risk to develop a potentially fatal complication. We currently recommend that all patients be hospitalized for at least 72 hr after the onset of therapy to assure a therapeutic response to therapy. If they do not respond within this period, we change the therapeutic regimen to emetine plus chloroquine (figure 5). Such an approach is particularly recommended for patients with abscesses of the left lobe, as they can rupture into the pericardium and cause a particularly high rate of mortality [15, 16] . Although metronidazole is an effective and nontoxic treatment of amebic liver abscess, treatment failures do occur. The careful monitoring for therapeutic response in the early course of the therapy permits early recognition of potential treatment failures and institution of alternate therapeutic modalities before complications ensue.
